Skip to main content
logo
Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.670
-0.060 (-1.27%)
Jul 31, 2026, 4:08 PM HKT

HKG:1167 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
53.5353.53155.7163.5295.75152.81
Revenue Growth
-73.42%-65.63%145.13%-33.66%-37.34%-68.58%
Gross Profit
52.9352.93155.713.212.6312.83
Operating Income
-166.24-166.24-203.19-411.95-480.93-292.31
Net Income
-145.98-145.98-155.71-359.12-371.86-301.19
Earnings Per Share
-0.19-0.19-0.20-0.46-0.49-0.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,1341,1341,1751,1481,2991,538
Total Debt
165.17165.17152.08209.91147.796.81
Net Cash (Debt)
968.51968.511,022937.931,1511,531
Net Cash Growth
12.00%-5.28%9.01%-18.50%-24.82%-5.32%
Net Cash Per Share
1.251.251.321.211.532.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-211.05-211.05-74.12-364.2-292.42-147.49
Capital Expenditures
-1.1-1.1-12.09-37.83-16.44-10.11
Free Cash Flow
-212.15-212.15-86.21-402.03-308.86-157.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
98.89%98.89%100.00%5.04%13.20%8.40%
Operating Margin
-310.59%-310.59%-130.49%-648.54%-502.29%-191.29%
Pretax Margin
-272.73%-272.73%-100.00%-565.36%-388.38%-197.10%
Profit Margin
-272.73%-272.73%-100.00%-565.36%-388.38%-197.10%
FCF Margin
-396.35%-396.35%-55.37%-632.92%-322.58%-103.13%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
61.4184.176.0540.9637.2859.64